FindTrial
Sign In

Study on the Role of Artificial Intelligence in the Diagnosis and Treatment of Autism

Study on the Role of Artificial Intelligence in the Diagnosis and Treatment of Autism

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067564
Enrollment
Unknown
Registered
2023-01-11
Start date
2023-01-11
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autistic Child

Interventions

Experimental group:EEG Biofeedback Treatment
Controlled group:Traditional rehabilitation treatment

Sponsors

Shenmu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Aged 3-10 years old; 2. The duration of treatment shall not exceed one year; 3. Sit still for at least 10 minutes; 4. Can cooperate with assessment and treatment; 5. CARS Scale > 30; 6. The patient or its authorized agent signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severely impaired cognition or inability to pay attention to and understand screen information; 2. Training interrupted for some reason.

Design outcomes

Primary

MeasureTime frame
Autism Behavior Checklist;Childhood Autism Rating Scale;CARS Scale;—

Secondary

MeasureTime frame
Swanson Nolan, and Pelham-IV rating scales;Conners Child Behavior Scale;—

Countries

China

Contacts

Public ContactLiu Juan

Shenmu Hospital

lj200722@163.com15029825466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026